Not sure why people continue to engage with @'slice of faecal matter', bored I guess! The fact is there is no other approved therapy for these kids, who have terrible survival odds with 'standard of care'; the fact is the insurers have listed Ryoncil as an approved therapy at pricing comparable to Car-T therapies. Yes of course the insurers will play their 'pre-approval' games and Mesoblast will have mechanisms in place for children who do not have sufficient insurance ... all standard practice. But the real joke is the pompous manner in which he "advises" the company -- hilarious from an anonymous penny stock keyboard warrior!!
MSB Price at posting:
$2.50 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)